Application of Yinhua Miyanling Pian in preparation of drug for reversing drug resistance of escherichia coli
A technology of Escherichia coli and Biyanling tablets, applied in the field of medicine, can solve the problems of prolonged clinical treatment time of infectious diseases and increased chances of infection recurrence
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0008] The present invention is further illustrated below by experiment.
[0009] 1. Materials and methods
[0010] 1.1 Materials
[0011] 1.1.1 Source of the strain: Escherichia coli ATCC 25922 was from the Laboratory of Pathogenic Microbiology, Jilin University.
[0012] 1.1.2 Experimental drugs:
[0013] Yinhua Biyanling Tablets (Jilin Huakang Pharmaceutical Co., Ltd., batch number: 101215); Levofloxacin (Zhejiang Hangkang Pharmaceutical Co., Ltd., batch number: 20110605)
[0014] 1.1.3 Experimental equipment:
[0015] Biological safety cabinet (BHC-1300ⅡA / B3 AIRTECH), UV spectrophotometer (2800UV / VIS, UNIC), high-speed low-temperature centrifuge (D-37520 Kendro), PCR instrument (EDC-810, Dongsheng Innovation Biotechnology Co., Ltd.) .
[0016] 1.1.4 Experimental reagents:
[0017] Nutrient Agar (Batch No.: 20111202), M-H Broth Medium (Batch No.: 20111125), Easy Taq DNA polymerase, High Pure dNTPs, Easy Taq 10×Buffer (TRAAS) , PCR Purification Kit (QIAGEN, Ge...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap